Get notified when DMRA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: DMRA Damora Therapeutics, Inc. 8-K

Damora completes redomestication from Delaware to Cayman Islands

Filed July 20, 2026 · Period ending July 16, 2026 · ~1 min read

Key Changes

  • high

    Completed redomestication from Delaware to Cayman Islands on July 16, 2026, following shareholder approval in February. All shares converted 1-for-1; business operations, management, and contracts unchanged.

  • medium

    Internal affairs now governed by Cayman Islands law instead of Delaware law, with certain shareholder rights modified under new memorandum and articles of association.

  • low

    Shares began trading under new CUSIP G2646Y104 on July 20, 2026, while retaining ticker symbol DMRA on Nasdaq. No certificate exchange required.

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (INTC 10-Q) is open in full — no account needed.

Partner

Trade DMRA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 28, 2026 · How we verify